Immunological efficacy of Jinhua Qinggan Granule for COVID-19

Not Applicable

• Conditions: COVID-19

• Registration Number: JPRN-UMIN000040407
• Lead Sponsor: Administration Department, Takanawa Clinic

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-05-15
• Study Completion: 2020-05-20
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

Not provided

Exclusion Criteria

Current infectious, inflammatory, or immune-related diseases

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plasma cytokine levels 1 hour after the administration of JHQG

Secondary Outcome Measures

Name	Time	Method
Hematology and blood biochemistry 1 hour after the administration of JHQG